Stock Track | Innovent Biologics Plummets 8.07% in Early Trading Following Founder's Share Sale

Stock Track05-15 10:36

Innovent Biologics (01801) saw its shares plummet 8.07% during early trading on Friday, marking a significant decline for the biotechnology company.

The sharp drop followed news that the company's founder, Chairman, and CEO, Dechao Yu, sold 1.353 million shares on May 11, 2026, at an average price of HK$89.362 per share, raising approximately HK$121 million. Following this transaction, his shareholding decreased to 7.49%, though he remains the largest single shareholder.

Despite the negative market reaction to the insider selling, China Post Securities noted that Innovent Biologics achieved its first full-year profit in 2025, signaling that its business model has proven successful. The company's gross profit margin benefited from economies of scale and improved production efficiency, while cash and cash equivalents stood at RMB 24.3 billion, providing a solid foundation for long-term development.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1131255002?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-15 10:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131255002","market":"hk","top_or_hot":-1,"title":"Stock Track | Innovent Biologics Plummets 8.07% in Early Trading Following Founder's Share Sale","media":"Stock Track","content":"<p>Innovent Biologics (01801) saw its shares plummet 8.07% during early trading on Friday, marking a significant decline for the biotechnology company.</p><p>The sharp drop followed news that the company's founder, Chairman, and CEO, Dechao Yu, sold 1.353 million shares on May 11, 2026, at an average price of HK$89.362 per share, raising approximately HK$121 million. Following this transaction, his shareholding decreased to 7.49%, though he remains the largest single shareholder.</p><p>Despite the negative market reaction to the insider selling, China Post Securities noted that Innovent Biologics achieved its first full-year profit in 2025, signaling that its business model has proven successful. The company's gross profit margin benefited from economies of scale and improved production efficiency, while cash and cash equivalents stood at RMB 24.3 billion, providing a solid foundation for long-term development.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Innovent Biologics Plummets 8.07% in Early Trading Following Founder's Share Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Innovent Biologics Plummets 8.07% in Early Trading Following Founder's Share Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-15 10:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Innovent Biologics (01801) saw its shares plummet 8.07% during early trading on Friday, marking a significant decline for the biotechnology company.</p><p>The sharp drop followed news that the company's founder, Chairman, and CEO, Dechao Yu, sold 1.353 million shares on May 11, 2026, at an average price of HK$89.362 per share, raising approximately HK$121 million. Following this transaction, his shareholding decreased to 7.49%, though he remains the largest single shareholder.</p><p>Despite the negative market reaction to the insider selling, China Post Securities noted that Innovent Biologics achieved its first full-year profit in 2025, signaling that its business model has proven successful. The company's gross profit margin benefited from economies of scale and improved production efficiency, while cash and cash equivalents stood at RMB 24.3 billion, providing a solid foundation for long-term development.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01801","symbol_name":"信达生物","start_time":0,"source_url":"","article_id":"1131255002","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131255002","pubTimestamp":1778812615,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Innovent Biologics (01801) saw its shares plummet 8.07% during early trading on Friday, marking a significant decline for the biotechnology company.The sharp drop followed news that the company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01801":"信达生物"},"translate_title":"个股赛道|方正售股后信达生物早盘暴跌8.07%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01801":1},"content_text":"Innovent Biologics (01801) saw its shares plummet 8.07% during early trading on Friday, marking a significant decline for the biotechnology company.The sharp drop followed news that the company's founder, Chairman, and CEO, Dechao Yu, sold 1.353 million shares on May 11, 2026, at an average price of HK$89.362 per share, raising approximately HK$121 million. Following this transaction, his shareholding decreased to 7.49%, though he remains the largest single shareholder.Despite the negative market reaction to the insider selling, China Post Securities noted that Innovent Biologics achieved its first full-year profit in 2025, signaling that its business model has proven successful. The company's gross profit margin benefited from economies of scale and improved production efficiency, while cash and cash equivalents stood at RMB 24.3 billion, providing a solid foundation for long-term development.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1131255002","isCrawlerRequest":true}